FindTrial
Sign In

STUDY OF COMMON ORGANISMS CAUSING AND EFFECTIVE DRUGS AGAINST THEM IN LACRIMAL SAC INFECTION IN CHILDREN

MICROBIOLOGICAL AND ANTIBIOTIC SENSITIVITY STUDY OF DACRYOCYSTITIS IN PAEDIATRIC AGE GROUP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/029877
Enrollment
25
Registered
2020-12-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H045- Stenosis and insufficiency of lacrimal passages

Interventions

None listed

Sponsors

Srikiran Institute of Ophthalmology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with age 0-5 years of either gender with dacryocystitis

Exclusion criteria

Exclusion criteria: 1. Children with a recent history (within the last 4 weeks) of topical antibiotic use in the affected eye/eyes. 2. All cases of pseudoepiphora and epiphora caused by diagnoses other than CNLDO. 3. Children above age of 5 years and adults.

Design outcomes

Primary

MeasureTime frame
1.current bacteriology of dacryocystitis in paediatric population. 2.Invitro susceptibilities and resistance to antibiotics. 3.Normal conjunctival microbial profile. Timepoint: At 2 weeks—

Secondary

MeasureTime frame
Type of the organism causing dacryocystitis in childrenTimepoint: 1year—

Countries

India

Contacts

Public ContactSUDHAKAR NAIDU LAVETI

Srikiran Institute of ophthalmology

avinash.mahindrakar@gmail.com9989988680

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026